Interdisciplinary Institute of Indian System of Medicine (IIISM), Department of Pharmaceutical Chemistry, SRM Institute Science and Technology, Kattankulathur, Tamil Nadu, India
Review
The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Critical Review
Author(s): Munwar S* and Ilango K
Thiazolidinediones are a class of well-established antidiabetic drugs, also named as glitazones. Thiazolidinedione structure has been an important structural domain of research,
involving design and development of new drugs for the treatment of type 2 diabetes. Extensive research on the mechanism of action and the structural requirements has revealed that
the intended antidiabetic activity in type 2 diabetes is due to their agonistic effect on peroxisome proliferator-activated receptor (PPAR) belonging to the nuclear receptor super family.
Glitazones have specific affinity to PPARγ, one of the subtypes of PPARs. Certain compounds under development have dual PPARα/γ agonistic activity which might be beneficial
in obesity and diabetic cardiomyopathy. Interesting array of hybrid compounds of thiazolidinedione PPARγ agonists exhibited therapeutic po.. Read More»
DOI:
10.37421/2161-0444.2020.10.547
Medicinal Chemistry received 6627 citations as per Google Scholar report